Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Inhaled hypertonic saline in infants and toddlers with cystic fibrosis: short-term tolerability, adherence, and safety.

Rosenfeld M, Davis S, Brumback L, Daniel S, Rowbotham R, Johnson R, McNamara S, Jensen R, Barlow C, Ratjen F.

Pediatr Pulmonol. 2011 Jul;46(7):666-71. doi: 10.1002/ppul.21425.

2.

Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.

Subbarao P, Balkovec S, Solomon M, Ratjen F.

Pediatr Pulmonol. 2007 May;42(5):471-6.

PMID:
17436328
3.

Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.

Rosenfeld M, Ratjen F, Brumback L, Daniel S, Rowbotham R, McNamara S, Johnson R, Kronmal R, Davis SD; ISIS Study Group..

JAMA. 2012 Jun 6;307(21):2269-77. doi: 10.1001/jama.2012.5214.

4.

Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial.

Ros M, Casciaro R, Lucca F, Troiani P, Salonini E, Favilli F, Quattrucci S, Sher D, Assael BM.

J Aerosol Med Pulm Drug Deliv. 2014 Apr;27(2):133-7. doi: 10.1089/jamp.2012.1034.

PMID:
23745525
5.

Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis.

Dellon EP, Donaldson SH, Johnson R, Davis SD.

Pediatr Pulmonol. 2008 Nov;43(11):1100-6. doi: 10.1002/ppul.20909.

PMID:
18828160
6.

Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.

Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF.

Pediatr Pulmonol. 1996 Feb;21(2):77-83.

PMID:
8882210
7.

Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis.

Robinson M, Hemming AL, Regnis JA, Wong AG, Bailey DL, Bautovich GJ, King M, Bye PT.

Thorax. 1997 Oct;52(10):900-3.

8.

[Tolerance of two inhaled hypertonic saline solutions in patients with cystic fibrosis].

Máiz Carro L, Lamas Ferreiro A, Ruiz de Valbuena Maiz M, Wagner Struwing C, Gabilondo Álvarez G, Suárez Cortina L.

Med Clin (Barc). 2012 Feb 4;138(2):57-9. doi: 10.1016/j.medcli.2011.02.022. Spanish.

PMID:
21511313
9.

Nebulised hypertonic saline for cystic fibrosis.

Wark PA, McDonald V.

Cochrane Database Syst Rev. 2003;(1):CD001506. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD001506.

PMID:
12535409
10.

Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis.

Laube BL, Sharpless G, Carson KA, Kelly A, Mogayzel PJ Jr.

BMC Pulm Med. 2011 Sep 6;11:45. doi: 10.1186/1471-2466-11-45.

11.

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.

Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group..

N Engl J Med. 2006 Jan 19;354(3):229-40.

12.

Nebulised hypertonic saline for cystic fibrosis.

Wark P, McDonald VM.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001506. doi: 10.1002/14651858.CD001506.pub3. Review.

PMID:
19370568
13.

The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.

Robinson M, Daviskas E, Eberl S, Baker J, Chan HK, Anderson SD, Bye PT.

Eur Respir J. 1999 Sep;14(3):678-85.

14.

Mucus clearance and lung function in cystic fibrosis with hypertonic saline.

Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC.

N Engl J Med. 2006 Jan 19;354(3):241-50.

15.

Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline.

Subbarao P, Stanojevic S, Brown M, Jensen R, Rosenfeld M, Davis S, Brumback L, Gustafsson P, Ratjen F.

Am J Respir Crit Care Med. 2013 Aug 15;188(4):456-60. doi: 10.1164/rccm.201302-0219OC.

16.

Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.

Robinson M, Regnis JA, Bailey DL, King M, Bautovich GJ, Bye PT.

Am J Respir Crit Care Med. 1996 May;153(5):1503-9.

PMID:
8630593
17.

Nebulised hypertonic saline for cystic fibrosis.

Wark PA, McDonald V, Jones AP.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001506. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD001506.

PMID:
16034863
18.

Timing of hypertonic saline inhalation for cystic fibrosis.

Elkins M, Dentice R.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008816. doi: 10.1002/14651858.CD008816.pub2. Review.

PMID:
22336853
19.

Inhaled mannitol for cystic fibrosis.

Nolan SJ, Thornton J, Murray CS, Dwyer T.

Cochrane Database Syst Rev. 2015 Oct 9;(10):CD008649. doi: 10.1002/14651858.CD008649.pub2. Review.

PMID:
26451533
20.

Hypertonic saline for cystic fibrosis: worth its salt?

Goralski JL, Donaldson SH.

Expert Rev Respir Med. 2014 Jun;8(3):267-9. doi: 10.1586/17476348.2014.896203.

PMID:
24666113
Items per page

Supplemental Content

Support Center